Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 0.45%.

  • Autolus Therapeutics' Return on Capital Employed fell 1700.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.47% for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Autolus Therapeutics' Return on Capital Employed stood at 0.45%, which was down 1700.0% from 0.41% recorded in Q2 2025.
  • Autolus Therapeutics' Return on Capital Employed's 5-year high stood at 0.23% during Q2 2024, with a 5-year trough of 0.58% in Q1 2021.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.35% (2023), whereas its average is 0.38%.
  • Per our database at Business Quant, Autolus Therapeutics' Return on Capital Employed surged by 3100bps in 2021 and then crashed by -1700bps in 2025.
  • Over the past 5 years, Autolus Therapeutics' Return on Capital Employed (Quarter) stood at 0.31% in 2021, then fell by -20bps to 0.38% in 2022, then crashed by -38bps to 0.52% in 2023, then skyrocketed by 38bps to 0.32% in 2024, then plummeted by -39bps to 0.45% in 2025.
  • Its Return on Capital Employed stands at 0.45% for Q3 2025, versus 0.41% for Q2 2025 and 0.38% for Q1 2025.